¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"electronic energy level"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • air fluid level
    °ø±â¾×üÃþ
  • alertness level
    °¢¼º¼öÁØ
  • background level
    ¹è°æ¼öÁØ
  • blood enzyme level
    Ç÷ÁßÈ¿¼Ò³óµµ
  • drug level monitoring
    ¾à¹°³óµµ°¨½Ã, ¾à¹°³óµµÃøÁ¤
  • effective perceived noise level
    ½ÇÈ¿°¨¼ö¼ÒÀ½¼öÁØ, ½ÇÁ¦°¨°¢¼ÒÀ½¼öÁØ
  • fat blood level
    Áö¹æÇ÷Ãþ
  • firing level
    ¹ßÈ­¼öÁØ
  • ground water level
    ÁöÇϼö³ôÀÌ
  • level
    1. ¼öÁØ 2. Ãþ 3. Ä¡ 4. ³óµµ
  • level of significance
    À¯ÀǼöÁØ
  • maximal expiratory level
    Ãִ볯¼û¼öÁØ, ÃÖ´ëÈ£±â°ª
  • maximal inspiratory level
    ÃÖ´ëµé¼û¼öÁØ, ÃÖ´ëÈí±â°ª
  • maximum permissible level
    ÃÖ´ëÇã¿ë¼öÁØ
  • maximum safe intensity level
    ÃÖ´ë¾ÈÀü°­µµ¼öÁØ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • nuclear energy
    ÇÙ¿¡³ÊÁö
  • potential energy
    À§Ä¡¿¡³ÊÁö, ÀüÀ§¿¡³ÊÁö
  • radiant energy
    ¹æ»ç¿¡³ÊÁö
  • thermal energy
    ¿­¿¡³ÊÁö
  • threshold energy
    ¹®Åο¡³ÊÁö
  • high energy radiation
    °í¿¡³ÊÁö¹æ»ç¼±
  • high linear energy transfer radiation
    °í¼±Çü¿¡³ÊÁöÀüÀ̹æ»ç¼±
  • linear energy transfer radiation
    ¼±»ó¿¡³ÊÁöÀüȯ
  • acceptable noise level
    Çã¿ë¼ÒÀ½¼öÁØ
  • air fluid level
    °ø±â¾×üÃþ
  • alertness level
    °¢¼º¼öÁØ
  • antimicrobial level
    Ç×±Õ¼öÁØ
  • audiometric level
    û·Â¼öÁØ
  • background level
    ¹è°æ¼öÁØ
  • blood enzyme level
    Ç÷ÁßÈ¿¼Ò³óµµ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • air fluid level
    °ø±â ¾×üÃþ
  • alertness level
    °æ°è±âÁØ(ÌíÌüÐññÞ).
  • antimicrobial level
    Ç×±ÕÁ¦Ä¡<¼öÁØ(â©ñÞ)>
  • audiometric level
    û·Â, û·Â·¹º§
  • blood alcohol level = blood alcohol concentration
    Ç÷Áß¾ËÄڿóóµµ
  • blood enzyme level
    Ç÷ÁßÈ¿¼Ò³óµµ.
  • blood oxygenation level dependant contrast
    Ç÷Áß »ê¼ÒÄ¡ ÀÇÁ¸ ´ëÁ¶µµ
  • blood oxygenation level dependant(BOLD)
    Ç÷Áß »ê¼ÒÄ¡ ÀÇÁ¸
  • carinal level
    ºÐ±â ´ë
  • control level
    °ü¸®¼öÁØ(Ë´ËöËàÌ¡).
  • decision level
    °áÁ¤¼öÁØ
  • developmental level
    ¹ß´Þ¼öÁØ(Û¡Ó¹â©ñÞ)
  • drug level monitoring
    ¾à¹°³óµµ°¨½Ã, ¾à¹°³óµµÃøÁ¤
  • effective perceived noise level =EPNDB
    ½ÇÈ¿°¨¼ö¼ÒÀ½(Ëà̷˧ËÛËÛËô)·¹ º§.
  • excess level
    °úÀ×¼öÁØ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • internal energy
    ³»ºÎ(Үݻ)¿¡³ÊÁö
  • ionization energy
    ÀÌ¿ÂÈ­(ûù) ¿¡³ÊÁö
  • ionizing energy
    ÀÌ¿ÂÈ­(ûù) ¿¡³ÊÁö
  • kinetic energy correction
    À¯µ¿(×µÔÑ) ¿¡³ÊÁö º¸Á¤(ÜÍïá)
  • linear energy transfer
    ¼±Çü(àÊû¡) ¿¡³ÊÁöÀüÀÌ(ï®ì¹)
  • low-energy compound
    Àú(î¸)¿¡³ÊÁöÈ­ÇÕ¹°(ûùùêÚª)
  • low-energy electron diffraction
    Àú(î¸)¿¡³ÊÁö ÀüÀÚȸÀý(ï³í­üÞï¹)
  • low-energy ion scattering
    Àú(î¸)¿¡³ÊÁö À̿ºлê(ÝÂߤ)
  • low-energy phophate acceptor
    Àú(î¸)¿¡³ÊÁö Àλê¼ö³³Ã¼(×òß«áôÒ¡ô÷)
  • noncollisional energy transfer
    ºñÃæµ¹(ÞªõúÔÍ)¿¡³ÊÁöÀü´Þ(îîÓ¹)
  • phosphate bond energy
    Àλê°áÇÕ(×ò߫̿ùê) ¿¡³ÊÁö
  • potential energy barrier
    "ÀüÀ§(ï³êÈ) ¿¡³ÊÁö À庮(î¡Ûú), ÆÛÅÙ¼È ¿¡³ÊÁö À庮"
  • potential energy diagram
    "ÀüÀ§(ï³êÈ) ¿¡³ÊÁö µµÇü(Óñû¡), ÆÛÅÙ¼È ¿¡³ÊÁö µµÇü(Óñû¡)"
  • potential energy well
    "ÀüÀ§(ï³êÈ) ¿¡³ÊÁö ¿ì¹°, ÆÛÅÙ¼È ¿¡³ÊÁö ¿ì¹°"
  • resonance energy transfer
    °ø¸í(ÍìÙ°) ¿¡³ÊÁö ÀüÀÌ(ï®ì¹)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
ECM electronic claims management; embryonic chick muscle; erythema chronicum migrans; experimental cereb...
EDDS electronic development delivery system
EDI eating disorder inventory; electronic data interchange
EDP electron dense particle; electronic data processing; end-diastolic pressure
EDSR electronic document storage and retrieval
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
BiPAP Bi-level positive airway pressure
BMLD binaural masking level difference
BAL Blood Alcohol Level
BOLD Blood Oxygenation Level Dependent
BGL Blood glucose level
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • substrate level phosphorylation
    ±âÁú±Þ ÀλêÈ­
  • ultrastructural level
    Ãʹ̼¼ ±¸Á¶Àû ¼öÁØ
    ÀÎü¸¦ ±¸¼ºÇÏ´Â ÃÖ¼Ò ¹Ì¼¼ ÀÔÀÚÀÇ ¼öÁØ. ±¤ÇÐÇö¹Ì°æÀÇ ÇØ»ó·ÂÀ» ³ÑÀº ÃÊÇö¹Ì°æÀ̳ª ÀüÀÚÇö¹Ì°æÇÏ¿¡¼­ óÀ½À¸·Î º¸ÀÌ´Â ±¸Á¶.
  • absorption energy
    Èí¼ö ¿¡³ÊÁö
  • atomic energy
    ¿øÀÚ ¿¡³ÊÁö
  • bond energy
    °áÇÕ ¿¡³ÊÁö
  • bound energy
    °áÇÕ ¿¡³ÊÁö
  • catabolism of energy
    ¿¡³ÊÁöÀÇ ÀÌÈ­ ´ë»ç
    »ì¾Æ ÀÖ´Â Á¶Á÷¿¡¼­ ÀÛ¾÷À̳ª ¿­·Î ¿¡³ÊÁö°¡ ¹ß»êµÇ´Â °Í. ÇÑ ´Ü°è´Â ´ë»ç ÀÛ¿ëÀ̰í, ÇÑ ´Ü°è´Â ÀÌÈ­ ´ë»çÀÌ´Ù.
  • dual energy
    ÀÌÁß ¿¡³ÊÁö
  • energetic exhibiting energy

    energetics

    ¿¡³ÊÁö·Ð, ¿¡³ÊÁöÇÐ
    ¿¡³ÊÁöÀÇ ¿¬±¸. ¿¡³ÊÁöÀÇ °úÇÐ.
  • energy
    ¿¡³ÊÁö
    1. ·¹ÀÌÀú¿¡ À־ ¿¡³ÊÁö´Â ½Ã°£°ú ÈûÀÌ °ö°ú °°´Ù. 2. ÀÏÀ» ÇÏ´Â ´É·Â, ¿îµ¿À» ÀÏÀ¸ÄѼ­ ÀúÇ×À» ±Øº¹ÇÏ¿© ¹°¸®Àû º¯È­¸¦ ÀÏÀ¸Å°´Â Èû.
  • energy charge
    ¿¡³ÊÁö ºÎÇÏ
  • energy dependency
    ¿¡³ÊÁö ÀÇÁ¸¼º
  • energy flux density
    ¿¡³ÊÁö¼Ó ¹Ðµµ
  • energy imparted
    ºÎ¿© ¿¡³ÊÁö
  • energy loss
    ¿¡³ÊÁö ¼Õ½Ç
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
lactic acid level <investigation> A test that measures the amount of lactic acid in the blood.
(25 Jun 1999)
free calcium level <biochemistry> The ionised calcium represents the calcium (Ca++) that is the metabolically active calcium. Normal values for ionised calcium in the bloodstream should be 4.4 to 5.3 mg/dl for adults and 4.4 to 6.0 mg/dl for children. Elevations may be seen in hyperparathyroidism, metastatic bone tumour, milk-alkali syndrome, multiple myeloma, Paget's disease, sarcoidosis, PTH-secreting tumours (paraneoplastic syndrome) and vitamin D intoxication. Lower than normal values may be seen in hypoparathyroidism, malabsorption, osteomalacia, pancreatitis, renal failure, rickets and vitamin D deficiency.
(27 Sep 1997)
level of aspiration <psychology> The degree or quality of performance (exhibited in a testing situation) which an individual desires to attain or feels he can achieve.
(05 Mar 2000)
activation energy <chemistry> The amount of energy (expressed in joules) that is needed to convert all the molecules in one mole of a reacting substance from a ground state to the transition state.
(06 May 1997)
binding energy <chemistry, radiobiology> The binding energy of a nucleus is the minimum energy required to dissociate it into its component neutrons and protons. Neutron or proton binding energies are those required to remove a neutron or proton, respectively, from a nucleus. Electron binding energy is that required to remove an electron from an atom or a molecule.
(16 Dec 1997)
bioelectric energy sources Implantable devices which convert biological energy (chemical energy of the metabolism of continuously regenerating body fluids or mechanical energy of periodic movements) to electrical energy. The sources include biogalvanic cells, biofuel cells, and ionic concentration cells.
(12 Dec 1998)
biomass energy See Bioenergy.
(05 Dec 1998)
bond dissociation energy This is the energy needed to break the bonds between two linked atoms.
(09 Oct 1997)
bond energy The energy needed to break a molecular bond.
(09 Oct 1997)
radiant energy Energy contained in light rays or any other form of radiation.
(05 Mar 2000)
radiography, dual-energy scanned projection A method of producing a high-quality scan by digitizing and subtracting the images produced by high- and low-energy X-rays.
(12 Dec 1998)
radiotherapy, high-energy Radiotherapy using high-energy (megavolt or higher) ionizing radiation. Types of radiation include gamma rays, produced by a radioisotope within a teletherapy unit; X-rays, electrons, protons, alpha particles (helium ions) and heavy charged ions, produced by particle acceleration; and neutrons and pi-mesons (pions), produced as secondary particles following bombardment of a target with a primary particle.
(12 Dec 1998)
Parallel Electron Energy Loss Spectroscopy <technique> Electron energy loss spectroscopy analyses the inelastically scattered electrons present in the beam after it has been transmitted through the sample. An electron energy loss spectrum typically consists of a monatomic decreasing background on which are superimposed a number of peaks. Each peak is characteristic of the scattering process that has occurred in the sample. The peaks can be used to obtain information about the chemical composition and electronic structure of the sample. Electron energy loss spectra are acquired typically in a magnetic sector spectrometer located under the camera chamber of the transmission electron microscope. Spatial resolution is typically limited by the minimum probe diameter of the microscope. Electron energy loss spectroscopy tends to be complimentary to EDS in that it can be used to analyse very thin samples of low Z materials.
Acronym: PEELS
(05 Aug 1998)
geothermal energy Energy derived from the natural heat of the Earth contained in hot rocks, hot water, hot brines or steam.
(05 Dec 1998)
mass energy absorption coefficient <physics> The mass energy absorption coefficient, uen/p of a material for uncharged ionising particles is the product of the mass energy transfer coefficient, utr/p and (1 - g) where g is the fraction of the energy of secondary charged particles that is lost to bremsstrahlung in the material.
(16 Dec 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • energy bush
    (¿¬·á,Àü·ÂÀÌ µÇ´Â)¿¡³ÊÁö¸²
  • energy crisis
    ¿¡³ÊÁö À§±â
  • energy flow
    (»ýŰèÀÇ)¿¡³ÊÁö È帧
  • energy industry
    ¿¡³ÊÁö »ê¾÷(¼®Åº,¼®À¯,Àü±â,°¡½º »ê¾÷ µî)
  • energy park
    (¹Ì)¿¡³ÊÁö ´ÜÁö;¿¡³ÊÁö ÀÚ¿ø °øµ¿ ÀÌ¿ëÁö
  • free energy
    ÀÚÀ¯ ¿¡³ÊÁö
  • kinetic energy
    ¿îµ¿ ¿¡³ÊÁö 
  • mass energy
    Áú·® ¿¡³ÊÁö
  • nuclear energy
    ÇÙ ¿¡³ÊÁö !
  • rest energy
    Á¤Áö¿¡³ÊÁö
  • solar energy
    ÅÂ¾ç ¿¡³ÊÁö !
  • Electronic Computer Originated Mail
    (¹Ì)ÄÄÇ»ÅÍ ¹ß½ÅÇü ÀüÀÚ ¿ìÆí
  • Electronic Yellow Pages
    ÀüÀÚ½Ä Á÷¾÷ ÀüÈ­ºÎ(ƯÁ¤ Á÷¾÷º° ÀüÈ­ºÎÀÇ Á¤º¸¸¦ ¿Â¶óÀÎÀ¸·Î Á¦°øÇÏ´Â µî)
  • electronic
    ÀüÀÚÀÇ
  • electronic art
    ÀüÀÚ ¿¹¼ú(¼¶±¤,¿òÁ÷ÀÌ´Â ¶óÀÌÆ® µîÀ» »ç¿ëÇÑ ¿¹¼ú ¾ç½Ä)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á